- Home
- SPHR vs PRCT Comparison
SPHR vs PRCT Comparison
Compare SPHR & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPHR
- PRCT
- Stock Information
- Founded
- SPHR 2020
- PRCT 2009
- Country
- SPHR United States
- PRCT United States
- Employees
- SPHR N/A
- PRCT N/A
- Industry
- SPHR Services-Misc. Amusement & Recreation
- PRCT Medical Specialities
- Sector
- SPHR Consumer Discretionary
- PRCT Health Care
- Exchange
- SPHR Nasdaq
- PRCT Nasdaq
- Market Cap
- SPHR 2.1B
- PRCT 1.8B
- IPO Year
- SPHR N/A
- PRCT 2021
- Fundamental
- Price
- SPHR $58.68
- PRCT $32.98
- Analyst Decision
- SPHR Buy
- PRCT Buy
- Analyst Count
- SPHR 8
- PRCT 8
- Target Price
- SPHR $55.13
- PRCT $67.14
- AVG Volume (30 Days)
- SPHR 991.2K
- PRCT 1.0M
- Earning Date
- SPHR 11-11-2025
- PRCT 11-04-2025
- Dividend Yield
- SPHR N/A
- PRCT N/A
- EPS Growth
- SPHR N/A
- PRCT N/A
- EPS
- SPHR N/A
- PRCT N/A
- Revenue
- SPHR $1,040,932,000.00
- PRCT $274,950,000.00
- Revenue This Year
- SPHR $9.94
- PRCT $48.38
- Revenue Next Year
- SPHR $9.84
- PRCT $30.87
- P/E Ratio
- SPHR N/A
- PRCT N/A
- Revenue Growth
- SPHR 1.37
- PRCT 55.71
- 52 Week Low
- SPHR $23.89
- PRCT $32.11
- 52 Week High
- SPHR $68.00
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- SPHR 52.21
- PRCT 34.38
- Support Level
- SPHR $59.65
- PRCT $32.11
- Resistance Level
- SPHR $63.49
- PRCT $35.14
- Average True Range (ATR)
- SPHR 2.99
- PRCT 1.72
- MACD
- SPHR -0.86
- PRCT 0.04
- Stochastic Oscillator
- SPHR 16.29
- PRCT 20.95
About SPHR Sphere Entertainment Co.
Sphere Entertainment Co is a live entertainment and media company. The firm creates, writes, casts, produces, and tours shows and events. The group has two reportable segments which includeSphere and MSG Networks. Sphere is a next-generation entertainment medium, and MSG Networks operates two regional sports and entertainment networks, as well as a direct-to-consumer (DTC) and authenticated streaming product.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.